留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

应中央军委要求,2022年9月起,《药学实践杂志》将更名为《药学实践与服务》,双月刊,正文96页;2023年1月起,拟出版月刊,正文64页,数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿!

脂微球载药系统的研究进展

章秀丽 马月琴 李刚

章秀丽, 马月琴, 李刚. 脂微球载药系统的研究进展[J]. 药学实践与服务, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
引用本文: 章秀丽, 马月琴, 李刚. 脂微球载药系统的研究进展[J]. 药学实践与服务, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
ZHANG Xiuli, MA Yueqin, LI Gang. Research development of lipid microsphere delivery system[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
Citation: ZHANG Xiuli, MA Yueqin, LI Gang. Research development of lipid microsphere delivery system[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003

脂微球载药系统的研究进展

doi: 10.3969/j.issn.1006-0111.2014.06.003
基金项目: 江西省自然科学基金项目(20122BAB215038).

Research development of lipid microsphere delivery system

  • 摘要: 脂微球递药系统是药剂学研究的热点,从脂微球载药系统的形成机制、构建方法及关键影响因素等方面进行综述,介绍该领域研究的进展和一些新发现,以促进脂微球作为药物载体的开发和应用。
  • [1] Liu ZZ, Feng YY, Zhang LL, et al. Pharmacokinetics and tissue distribution of larotaxel in rats: comparison of larotaxel-loaded microsphere with larotaxel-solution[J]. Cancer Chemother Pharmacol, 2013, 71(5): 1131-1139.
    [2] McClements DJ. Advances in fabrication of emulsions with enhanced functionality using structural design principles[J]. Curr Opin Colloid Interf Sci, 2012, 17(5): 235-245.
    [3] Groves MJ. The redistribution of bulk aqueous phase phospholipids during thermal stressing of phospholipid-stabilized emulsions[J]. Pharm Pharmacol, 1993, 45(7): 592.
    [4] Morais JM, Burgess DJ. Long acting injections and implants: micro-and nano-emulsions (controlled release parenteral drug delivery systems)[M].London: Springer, 2012: 221-238.
    [5] Yue PF, Lu XY, Liao MX, et al. The effect of oil components and homogenization conditions on the physicochemical properties of zedoary turmeric oil submicron emulsions[J]. J Dispers Sci Technol, 2010, 31(11):1535-1540.
    [6] Patel R, Joshi J. An overview on nanoemulsion: a novel approach[J]. Int J Pharml Sci Res, 2012, 3(12): 4640-4650.
    [7] Bague S, Philips B, Rabinovich-Guilatt L, et al. Ophthalmic oil-in-water type emulsion with stable zeta potential[P].USA WO2006050838 A2, 2005-10-10.
    [8] Akkar A, Muller RH. Intravenous itraconazole emulsions produced by SolEmuls technology[J]. Eur J Pharm Biopharm, 2003, 56(1): 29-36.
    [9] Müller RH, Schmidt S, Buttle I, et al. SolEmuls®-novel technology for the formulation of i.v. emulsions with poorly soluble drugs[J]. Int J Pharm, 2004, 269(2): 293-302.
    [10] Yue PF, Li FQ, Liao MX, et al. Process optimization, characterization, and release study in vitro of an intravenous puerarin lipid micropheres loaded with the phospholipid complex[J]. J Dispers Sci Technol, 2011, 32(1): 1-10.
    [11] Yue PF, Zheng Q, Wu B, et al. Application of plackett-burman design and box-behnken design to achieve process optimization for geniposide submicron emulsion[J]. J Dispers Sci Technol, 2012, 33(2): 213-222.
    [12] Ma YQ, Li G, Xu JH, et al. Combination of submicroemulsion and phospholipid complex for novel delivery of ursodeoxycholic acid[J]. Pharm Dev Technol,2014,19(3):363-372.
    [13] Gulati Neha, Gupta Himanshu. Parenteral drug delivery: a review[J]. Recent Patent Drug Deliv Form, 2011, 5(2): 133-145.
    [14] Yamamura K, Nakao M, Yano K, et al. Stability of forskolin in lipid emulsions and oil/water partition coefficients[J]. Chem Pharm Bull,1991, 39(4):1032-1034.
    [15] Bhalerao AV, Singh SS. In situ gelling ophthalmic drug delivery system for glaucoma[J]. Int J Pharm Biosci, 2011, 2(2): 7-14.
    [16] Patel Y, Poddar A, Sawant K. Formulation and characterization of Cefuroxime Axetil nanoemulsion for improved bioavailability[J]. J Pharm Bioallied Sci, 2012, 4(1): S4-S5.
    [17] Ammar H, Salama H, Ghorab M, et al. Nanoemulsion as a potential ophthalmic drug delivery system for Dorzolamide hydrochloride[J]. AAPS Pharm Sci Tech, 2009, 10(3): 808-819.
    [18] Gan L, Wang J, Jiang M, et al.Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers[J]. Drug Discov Today, 2013, 18(5-6): 290-297.
    [19] Lu Y, Qi J, Wu W. Absorption, disposition and pharmacokinetics of nanoemulsions[J]. Curr Drug Metab,2012, 13(4): 418-428.
    [20] Sultana Y, Maurya DP, Iqbal Z,et al. Nanotechnology in ocular delivery: current and future directions[J]. Drugs Today, 2011, 47(6): 441-455.
    [21] Zhang N, Zhang Q, Chu T, et al. Formulation optimization of prostaglandin E1-loaded lipid emulsion: enhanced stability and reduced biodegradation[J]. Pharm Dev Tech, 2013, 18(4): 804-812.
    [22] GaoY, Xu PF, Chen LL, Li YP. Prostaglandin E1 encapsulated into lipid nanoparticles improves its anti-inflammatory effect with low side-effect[J]. Int J Pharm, 2010, 387(1-2): 263-271.
    [23] Ueki R, Tanimoto M, Tatara T, et al. Emulsion of flurbiprofen axetil reduces propofol injection pain due to a decrease in free propofol concentration[J]. J Anesth, 2007, 21 (3): 325-329.
    [24] Shen J, Gan L, Zhu C, et al. Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect[J]. Int J Pharm, 2011, 412(1-2):115-122.
  • [1] 陈兰, 何晓莉, 游飘雪, 王辉, 洪战英.  基于微流控芯片的体外肠道吸收模型构建及其应用进展 . 药学实践与服务, 2024, 42(2): 43-49, 59. doi: 10.12206/j.issn.2097-2024.202305003
    [2] 黄文辉, 许燕玉, 郝晓伟, 林冠, 欧阳山丹, 王佳坤, 陈锦珊.  奈玛特韦片/利托那韦片治疗COVID-19早期预后不良的危险因素及预测模型构建 . 药学实践与服务, 2023, 41(11): 700-704. doi: 10.12206/j.issn.2097-2024.202303038
    [3] 陈昕璐, 高原, 李鹃鹃, 郭欢欢, 王卓, 高申.  mRNA脂质纳米粒载药系统的构建及体外评价 . 药学实践与服务, 2023, 41(5): 291-295. doi: 10.12206/j.issn.2097-2024.202302026
    [4] 王琦, 卢光照, 李园, 樊莉, 张翮, 鲁莹.  河豚毒素缓释微球含量测定方法的建立 . 药学实践与服务, 2023, 41(3): 182-186. doi: 10.12206/j.issn.2097-2024.202208060
    [5] 仰先蜜, 许小建, 王学彬, 王卓, 王桐生.  头孢拉定微透析体外回收率及影响因素的研究 . 药学实践与服务, 2020, 38(2): 120-123, 128. doi: 10.3969/j.issn.1006-0111.201910044
    [6] 曹爱霖, 唐彦玲, 钱皎, 王卓.  前列地尔脂微球注射液临床超说明书用药干预分析 . 药学实践与服务, 2018, 36(5): 475-478. doi: 10.3969/j.issn.1006-0111.2018.05.022
    [7] 秦翠英, 李荣丽, 李云晶, 陈仁财, 韩静.  响应面法优化肉苁蓉松果菊苷肠溶微球的制备 . 药学实践与服务, 2017, 35(5): 411-414,432. doi: 10.3969/j.issn.1006-0111.2017.05.006
    [8] 杨阳, 高永良.  盐酸噻吩诺啡缓释微球的体外释放度及其体内外相关性研究 . 药学实践与服务, 2010, 28(5): 369-371,382.
    [9] 徐立平, 朱斌.  微球的近红外漫反射光谱聚类分析鉴别 . 药学实践与服务, 2009, 27(1): 61-62.
    [10] 康现武, 王强, 王毅, 顾其胜, 蒋丽霞.  甲硝唑羧甲基壳聚糖缓释微球的制备及体外释放 . 药学实践与服务, 2008, (3): 182-184.
    [11] 王新霞, 龚纯贵, 赵卫红, 钟延强.  微球在肝肿瘤介入治疗中的应用 . 药学实践与服务, 2008, (4): 245-248.
    [12] 陈建明, 叶丽卡, 高申, 毛世瑞, 毕殿洲.  褪黑激素明胶微球剂与溶液剂鼻粘膜给药比较 . 药学实践与服务, 2001, (5): 280-281.
    [13] 傅应华.  国内微球剂的最新研究进展 . 药学实践与服务, 2001, (5): 284-286.
    [14] 张万国, 胡晋红, 蒋雪涛, 傅崇东, 张川.  聚乳酸分子量对利福平聚乳酸微球性质的影响 . 药学实践与服务, 2000, (4): 216-217,218.
    [15] 钟延强, 蒋雪涛, 孙其荣.  白蛋白微球制剂(续) . 药学实践与服务, 1995, (5): 288-292.
    [16] 钟延强, 蒋雪涛, 孙其荣.  白蛋白微球制剂 . 药学实践与服务, 1995, (4): 208-211.
    [17] 要芬梅, 肖大卫, 郑爱萍, 沈颜红, 高云峰.  5-氟尿嘧啶聚乳酸微球的制备和性质 . 药学实践与服务, 1993, (2): 122-125.
    [18] 要芬梅, 李新芳, 朱光文, 高云峰, 沈颜红, 郑爱萍.  5-氟尿嘧啶聚乳酸微球的药代动力学研究 . 药学实践与服务, 1993, (4): 261-265.
    [19] Y.Mizushima.  消炎痛酯脂质微球的抗炎作用 . 药学实践与服务, 1985, (2): 7-7.
    [20] 管延臣, 吴金虎.  微脂粒有益于药物的皮肤释放 . 药学实践与服务, 1983, (2): 15-15.
  • 加载中
计量
  • 文章访问数:  3492
  • HTML全文浏览量:  316
  • PDF下载量:  259
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-05-21
  • 修回日期:  2014-03-17

脂微球载药系统的研究进展

doi: 10.3969/j.issn.1006-0111.2014.06.003
    基金项目:  江西省自然科学基金项目(20122BAB215038).

摘要: 脂微球递药系统是药剂学研究的热点,从脂微球载药系统的形成机制、构建方法及关键影响因素等方面进行综述,介绍该领域研究的进展和一些新发现,以促进脂微球作为药物载体的开发和应用。

English Abstract

章秀丽, 马月琴, 李刚. 脂微球载药系统的研究进展[J]. 药学实践与服务, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
引用本文: 章秀丽, 马月琴, 李刚. 脂微球载药系统的研究进展[J]. 药学实践与服务, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
ZHANG Xiuli, MA Yueqin, LI Gang. Research development of lipid microsphere delivery system[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
Citation: ZHANG Xiuli, MA Yueqin, LI Gang. Research development of lipid microsphere delivery system[J]. Journal of Pharmaceutical Practice and Service, 2014, 32(6): 409-411,459. doi: 10.3969/j.issn.1006-0111.2014.06.003
参考文献 (24)

目录

    /

    返回文章
    返回